Novonesis AS

Director's Dealing • Nov 25, 2009

TRADING BY MANAGEMENT IN NOVOZYMES A/S B SHARES

November 25, 2009

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.

Name	Relation/ Category of close relation	Trading date	Character of the transaction	No. of shares traded Buy (+) / Sell (-)	Market value of shares traded (DKK)
Steen Riisgaard	President & CEO	24/11 2009	Share options	+ 5,559 - 5,559	883,881 2,795,677

Contact persons:

Press and media:	Investor relations:
Annegrethe M. Jakobsen (Europe)	Tobias Bjørklund
Tel. (direct): +45 4446 3050	Tel. (direct): +45 4446 8682
Tel. (mobile): +45 3077 3050	Tel. (mobile): +45 3077 8682
Paige Donnelly (USA)	Thomas Bomhoff (USA)
Tel. (direct): +1 919 494 3209	Tel. (direct): +1 919 494 3483

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Company announcement no. 14, 2009 Page 1 of 1 Novozymes A/S Investor Relations

Tel. (mobile): +1 919 218 4501

Krogshøjvej 36 2880 Bagsværd Denmark

Telephone: +45 4446 0000 Fax: +45 4446 9999

Tel. (mobile): +1 919 649 2565

Internet: www.novozymes.com CVR number: 10 00 71 27